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Abstract 
The results of a characterisation study of water samples collected from an Advanced 
Water Recycling Plant (AWRP) operating in Perth, Western Australia are presented. 
The AWRP treats secondary wastewater by ultrafiltration, reverse osmosis (RO) and 
ultraviolet radiation (UV) to produce recycled water for groundwater replenishment. 
Water samples collected after RO and UV treatment were characterised by liquid 
chromatography-high resolution mass spectrometry, using an established protocol 
for target screening. The target screening of 291 compounds detected a total of 13 
chemicals in post-RO and post-UV water, including 2 corrosion inhibitors (4+5-
Methyl-1H-benzotriazole, benzotriazole), 3 pesticides (metolachlor, propiconazol, 
prosulfocarb), 3 pharmaceuticals (lamotrigin, metformin, tramadol), 1 personal care 
product (galaxalidone), 3 artificial sweeteners (saccharin, acesulfame, sucralose) 
and 1 flame retardant (triethyl phosphate). The corrosion inhibitors benzotriazole and 
4+5-Methyl-1H-benzotriazole, and the pharmaceutical metformin were detected in 
hundreds of ng/L, while concentrations of the other compounds were present in low 
ng/L concentrations. Analysis of UV treated water samples showed that UV 
treatment also helped to reduced UV degradable compounds such as the corrosion 
inhibitors (>50% removal), triethyl phosphate (~50% removal) and the artificial 
sweetener acesulfame (~95% removal). Overall, the detection of 13 chemicals 
through target screening analyses did not account for the residual dissolved organic 
carbon (DOC) in post RO water, the majority of which is still an intriguing unknown. 
However, the target screening did show that there were no obvious “known” 
anthropogenic contaminants contributing to the majority of the DOC in post-RO and 
post-UV treated water. Calculated risk quotients (RQ) for all detected chemicals in 
UV treated water were 2 to 6 order of magnitude below 1, implying an high degree of 
safety associated with human consumption of recycled water. Overall the chemicals 
screening provided further evidence of the overall safety of the use of recycled 






While research into the chemical safety of recycled water has focussed on 
measuring chemicals in recycled water, it is not clear what percentage of residual 
dissolved organic carbon (DOC) in recycled water results from anthropogenic 
chemicals. Here we show that anthropogenic chemicals do not contribute 
significantly to residual DOC in recycled water after RO and UV treatment. A risk 
assessment of the chemicals detected in the recycled water also demonstrates the 
high degree of safety associated with human consumption of recycled water. 
However, the study also highlights that end-product compliance testing for all 
potential chemicals is time consuming and expensive. Further research into the use 
of bioassays as a monitoring tool for water recycling is recommended.  
 
Introduction 
In recent years, Western Australia has experienced a significant reduction in 
rainwater precipitation levels which has corresponded to a reduction in water 
available from dams and groundwater for drinking water production.1 Use of treated 
wastewater as a drinking water source is becoming increasingly attractive, both in 
Australia and worldwide, and demonstrating that specific treatment technologies 
produce safe drinking water is of high importance, particularly focussing on chemical 
removal using reverse osmosis (RO) followed by ultraviolet irradiation (UV) for 
disinfection.  Research into the safety of recycled water has focussed on monitoring 
and characterising residual concentrations of inorganic and organic micropollutants 
in the finished water.2-4 Chemicals in wastewaters that potentially pose health 
concern include heavy metals, organic compounds with suspected carcinogenic 
properties (e.g. N-nitrosamines and halogenated disinfection by-products), 
pharmaceuticals and personal care products (e.g. endocrine disrupting compounds, 
cytostatics and antibiotics), pesticides and their degradation products, and other 
unregulated trace organic compounds (i.e. plasticisers, surfactants, musk 
fragrances, artificial sweeteners) derived from both domestic and industrial 
activities.4,5 Therefore residual dissolved organic carbon (DOC) present in RO-
treated wastewater may consist of anthropogenic organic compounds, in addition to 
residual organic matter originally present in drinking water and wastewater, or 
chemicals used during RO treatment or leached from RO membranes.6,7 Very few 
attempts to characterise this residual DOC have been reported to date,8,9 although a 
recent assessment of 375 chemicals in recycled water suggested that only ~2-5% of 
DOC in the RO treated water could be attributed to regularly detected (>25% 
detection) anthropogenic chemicals.10 In this work we present the results of a 
characterisation study of recycled water collected from an Advanced Water 
Recycling Plant (AWRP) located in Perth (WA) after both RO and UV treatment over 
four days. The water samples were extracted using mixed bed solid-phase extraction 
cartridges and then characterised by liquid chromatography-high resolution mass 
spectrometry.  
While almost 400 chemicals were screened previously in RO treated wastewater 
from a Perth wastewater treatment plant,5 particular emphasis in this work was given 
to polar chemicals amendable by LC-MS. The target screening in this study 
assessed the occurrence of 291 chemicals including pharmaceuticals (88 
compounds), pharmaceutical-metabolites (27 compounds), illicit drugs and 
metabolites (14 compounds), pesticides (79 compounds), pesticide-metabolites (51 
compounds), biocides and metabolites (11 compounds), artificial sweeteners (6 
compounds), personal care products (3 compounds), corrosion inhibitor and 
metabolites (5 compounds), industrial chemicals (5 compounds) and miscellaneous 
(2 compounds). Chemicals were selected based on 1) prior knowledge of their 
occurrence in wastewater inflow and outflow; 2) existing studies of recycled water 
and surface waters from previous surveys and literature.4,5,10,11 A snapshot of the 
chemicals and their transformation products and metabolites assessed in the target 
screening analysis is given in Figure 1 and the full list of the chemicals is reported in 
Table S1 available in the Supporting Information. Eighty five percent (248 of 291) of 
the target compounds were analysed in the Perth AWRP for the first time in this 
study. The contribution of detected chemicals to the residual dissolved organic 
carbon (DOC) measured in UV treated water was also assessed. For a screening 
health risk assessment, risk quotients (RQ) were calculated by comparing median 
and maximum concentrations of chemicals measured in UV treated water with the 




Samples were collected on four days (16/01/12 to 19/01/12), from an AWRP in 
Perth, Western Australia. Details of the AWRP have been previously published,11-13 
but briefly, the AWRP receives secondary wastewater (WW) from Beenyup WWTP 
and produces high purity recycled water that is then injected into a deep drinking 
water aquifer. Beenyup WWTP receives predominantly urban residential wastewater, 
and the raw WW is screened to remove large material, before grit removal and 
primary sedimentation. The primary treated WW then undergoes conventional 
activated sludge treatment with biological nutrient removal before clarification. Most 
secondary WW from Beenyup WWTP is discharged into the Indian Ocean, while a 
small portion (7 ML/d) is fed into the AWRP. Treatment at the AWRP consists of 
chloramination to minimise biofouling on membranes, ultrafiltration, reverse osmosis, 
and UV disinfection. A caustic dosing between the UV reactors is also present to 
adjust the pH to neutral conditions before the product water is degassed, stored and 
reinjected into the groundwater. After UF/RO/UV treatment, about 4.5 ML/d are 
reinjected into the groundwater aquifer, while the RO reject (about 2.5 ML/d) is sent 
back to the head of the WWTP. A schematic of the treatment train at Beenyup 
WWTP-AWRP including sampling points is shown in Figure 2. 
Grab samples were collected directly after RO and UV treatment (i.e. after caustic 
dosing, see Figure 2) in 2 L amber glass bottles, previously annealed at 550 °C 
overnight to ensure thermal degradation of and residual organic material. Bottles 
were also rinsed with the sample prior to sample collection. Sample were chilled with 
ice packs during transport to the CWQRC laboratory, and then stored at 4 ºC until 
extraction. Prior to processing though solid-phase extraction (SPE), all samples were 
re-equilibrated to room temperature and then filtered through 0.45 µm 
Microfiberglass Duo-Fine® Filter cartridges (PALL Life Sciences, East Hills, USA) 
pre-conditioned with 10 L of ultrapure water. To avoid cross contamination, a single 
filter cartridge was dedicated to each type of water processed. Quality control 
samples consisted of post RO water and laboratory ultrapure water, fortified with 
different concentrations of standards and surrogate standards. Laboratory blanks 




2.2 Sample extraction  
Because of the low concentrations expected in the post RO and post UV water 
samples, solid-phase extraction (SPE) as described by Kern et al.14 was used to 
concentrate the analytes from the samples. Briefly, the pH of each sample (2 L) was 
adjusted to 6.5−6.7 by adding 1 mL of ammonium acetate buffer (1 mol/L) and formic 
acid or ammonia solutions as required. For accurate quantification using LC-MS 
analysis, 100 ng of a surrogate standard mix containing 113 isotopically labelled 
substances were spiked to each sample. The layered ‘mixed bed’ cartridges for SPE 
consisted of 200 mg of OASIS HLB material (30 micro-M; Waters AG, USA) and 
mixed phase (350 mg in all: 100 mg Strata-X-AW (Phenomenex, USA), 100 mg 
Strata-X-CW (Phenomenex, USA), 150 mg Isolute ENV+ (Separtis GmbH, 
Germany). An automated Aspec XLi extractor (Gilson, USA) was used for 
conditioning and elution of the cartridges. For conditioning, 5 mL of methanol and 
10 mL of ultrapure water were dispensed at 2 mL/min. After conditioning, samples  
were loaded onto the SPE cartridges using two 8-channel off-line peristaltic pumps 
(Gilson) at a flow rate of 5 mL/min. Prior to elution, cartridges were completely dried 
using a vacuum manifold. The elution of the analytes from the SPE stationary phase 
was achieved by applying a basic solution (8 mL of ethylacetate/methanol containing 
0.5% ammonia hydroxide (v/v)), followed by an acidic solution (4 mL of 
ethylacetate/methanol containing 1.7% formic acid (v/v)) dispensed at 2 mL/min. The 
eluates were concentrated to about 100 µL using a dry block heater (30°C) fitted with 
nitrogen blowdown (Ratek 30D, Australia), before being rediluted to 1 mL using ultra 
pure water. Finally, the extracts were filtered directly into a 2 mL brown glass vial 
using a syringe fitted with a 0.45 µm regenerated cellulose membrane filter 
(Infochroma AG, Switzerland). Samples extracts chilled with ice packs were shipped 
using an international express delivery service to EAWAG laboratories in Dübendorf 
(Switzerland) for analysis. 
 
2.3 Chromatographic separation 
For the reversed phase chromatographic separation, an aliquot of the extract (20 µL) 
was injected onto a XBridge C18 column (Waters USA, 2.1 x 50 mm, 3.5 µm particle 
diameter) using a guard column (2.1 x 10 mm) of the same stationary phase. The 
eluent consisted of nanopure water (eluent A) and methanol (eluent B), both 
containing 0.1% (v/v) formic acid. The LC gradient used for the separation was as 
follows: 0 – 4 min, eluent B was increased from 10 - 50%; 4 – 17 min, eluent B was 
increased from 50 – 95%, then continued at 95% for 8 minutes. Prior to the next 
injection, the column was re-equilibrated with 90% eluent A and 10 % eluent B for 5 
min. The eluent flow rate was 0.2 mL/min at a temperature of 30 °C. 
 
2.4 Detection and quantification using high resolution mass spectrometry (HRMS) 
Analytes were detected using a high resolution mass spectrometer (Q Exactive; 
Thermo Fisher Scientific Corporation, USA). Ionisation of analytes was achieved 
using electrospray ionisation (ESI) operated in both positive (+eV) and negative (-eV) 
modes. The ESI and HRMS settings are reported in Table S2, available in the 
Supporting Information. A screening analysis was conducted where the selected 
target analytes were recorded using Q Exactive mass spectrometer full-scan spectra 
from 100-1000 m/z with a mass resolution (R) of 140,000 (@ 200 m/z) in positive 
and negative ionisation mode. For confirmation, all target analytes were fragmented 
in the HCD collision cell (high energy collision dissociation) using a data-dependent 
MS2 fragmentation approach. The top 5 MS2 spectra were measured in the Orbitrap 
mass analyser with a resolution of 17,500, normalized collision energies ranged from 
20-100%. 
 
2.5 Data processing and quantification 
A target screening was conducted on the Q Exactive raw data files using the 
software package enviMass 1.2 15. Peak lists for each sample were generated from 
raw data files using the freely available peak picking software Formulator (rev3, 
Thermo Fisher Scientific). Parameters for both the enviMass 1.2 and the Formulator 
software are listed in Table S3-S4 available in the Supporting Information. Peak lists 
were then loaded into the enviMass1.2 software for a qualitative target screening of 
291 target substances. Positive detects were manually reprocessed and quantified 
using the Xcalibur 2.2 QuanBrowser Software (Thermo Fisher Scientific). 
Quantification was performed with seven extracted standard samples containing all 
spiked target compounds with concentrations of 1, 5, 10, 25, 50, 100 ng/L and a 
blind sample (extracted nanopure water with spiked internal standards mix).  
For quality control, the relative SPE recoveries of the method were determined. One 
matrix sample constituted of post RO water was split in two equal portions. The first 
portion was spiked with 100 ng/L of standard mix and labelled surrogates while the 
second portion was treated as a blank and spiked with the labelled surrogates only, 
Both samples were treated exactly as the other samples in the batch. Relative 
deviations of recoveries within ± 30% were accepted (See Table S5 available in the 
Supporting Information). 
All detected substances were confirmed using the data-dependend MS2 spectra 
which were compared against single substance injection MS2 spectra acquired in 
house with varying collision energies.  
 
3. Results and Discussion 
3.1 Compounds detected in RO treated water  
Table 1. Concentration range (min–max) and median concentration (ng/L) of 
detected target compounds in post RO and post UV water samples collected from 
Beenyup AWRP on four different days (16/01/12 – 19/01/12). The average UV 
removal with the relative standard deviation is also reported. 
 
Chemicals 
















750–900 775 350–400 375 53±6 
Benzotriazole 750–1300 800 375–550 412 51±5 
Galaxalidone 15–52.5 29 5–30 14 37±48 
Lamotrigin 5–5 5 2.5–5 2.5 N/A 
Metolachlor <1*–7.5 3.75 0.5**–5 2.5 N/A 
Metformin 65–105 99 87.5–110 95 N/A 
Propiconazole 5–8 7.5 2.5–7.5 6.25 N/A 
Prosulfocarb 2.5**–5 5 <5*–5 5 N/A 
Tramadol 0.5**–475*** 0.5** 0.5**–100*** N/A N/A 
Acesulfame 25–35 26 <1*–2.5 N/A 95±2 
Saccharin <1*–2.5 2.5 <1*–5 5 N/A 
Sucralose 2.5–10 10 2.5–10 8.75 N/A 
Triethyl 
phosphate 
200–200 200 100–100 100 50±N/A 
*LOQ; ** tentatively quantified; N/A: not available; ***outlier 
 
The concentrations of detected chemicals in RO treated water are reported in Table 
1. Only 13 of the 291 chemicals targeted (i.e. ~4.5 %) were detected in RO water, 
although these chemicals were frequently detected in either 3 or 4 of the 4 sampling 
events. The chemicals detected included two corrosion inhibitors (4+5-Methyl-1H-
benzotriazole and benzotriazole), three pesticides (metolachlor, propiconazol, 
prosulfocarb), three pharmaceuticals (lamotrigin, metformin, tramadol), 1 personal 
care product metabolite (galaxalidone), three artificial sweeteners (acesulfame, 
saccharin and sucralose) and 1 industrial chemical (triethyl phosphate). Most 
chemicals were detected at a concentration less than 50 ng/L. However, the 
corrosion inhibitors chemicals benzotriazole and 4+5-Methyl-1H-benzotriazole, the 
pharmaceutical metformin and the industrial chemical triethyl phosphate were 
detected at much higher concentrations, between 65 and 1300 ng/L.  
Benzotriazole and its derivatives, including 4+5-Methyl-1H-benzotriazole are high 
volume production chemicals, with an estimated worldwide production of 
benzotriazoles in excess of 9000 tons/year.16,17 They are commonly used in paints 
and polymers as UV absorbers, detergents, antifreeze, brake fluids and in aircraft 
de-icing fluids as corrosion inhibitors18 and they are extensively found in WW and the 
environment.19 They have been found to be acutely toxic to specific species,20 but 
their chronic toxicity is not well studied. Benzotriazole and 4+5-Methyl-1H-
benzotriazole were consistently detected in relatively high concentration ranges in 
RO treated water, and this is expected given the µg/L concentrations previously 
detected in Beenyup secondary treated WW,12 the relatively low MW (<150 Da) and 
the high water solubility and mobility (log Kow = 1.23 for benzotriazole and log Kow = 
1.89 for 4+5-Methyl-1H-benzotriazole, see Table S5 available in the Supporting 
Information). These results are also consistent with our previous findings, which 
showed benzotriazole and 4+5-Methyl-1H-benzotriazole concentrations in RO 
treated water averaging 974 (±28) ng/L and 416 (±34) ng/L, respectively.12 
Galaxolidone, is a metabolite of galaxolide, a polycyclic musk widely used as a 
fragrance in personal care and consumer products including cosmetics, cleaning 
agents, detergents, air fresheners and perfumes.21 Galaxolidone results from the 
degradation of the parent compound galaxolide during biological activated 
sludge.22,23 Given their high log Kow (5.9 and 5.3 respectively), both galaxolide and 
galaxolidone can concentrate in blood, fat24 and breast milk.25 Synthetic musks can 
affect androgen and progesterone receptors and also stimulate estrogenic receptors 
in humans.26 Polycyclic musks have been reported in water bodies and biota 
previously.27 The median concentration of galaxolidone in RO treated water was 29 
ng/L. However, galaxalidone was also detected in the CWQRC laboratory blanks at 
10 ng/L (data not shown). This contamination could have resulted from an accidental 
exposure of the laboratory blank to the chemical at the time of sample collection or 
during the sample preparation process. Galaxolide and its metabolite galaxalidone 
will preferentially absorb onto plastic and glass (i.e. SPE equipment) and therefore 
are prone to cross-contamination. Despite this cross-contamination issue, it is still 
likely that low ng/L concentration of galaxolidone are present in RO treated water. 
The parent compound galaxolide was previously measured in wastewater and 
recycled samples from Beenyup WWTP and AWRP.11 Even though galaxolidone is 
neutral, based on the scheme proposed by Bellona et al.7 the physical-chemical 
properties of this chemical (MW > Molecular weight cut off (MWCO) of the 
membrane, approximately 150-200 Da, and log Kow > 2), a moderate to high rejection 
is expected during RO treatment. Given the high volume of usage and high 
concentration of galaxolide in WW11 and the high hydrophobicity of galaxolidone, it 
may have accumulated on the membranes and eventually achieved breakthrough 
from diffusion phenomena.7 
The median concentration of the industrial chemical triethyl phosphate in RO treated 
water was 200 ng/L. Triethyl phosphate is a common flame retardant, a polymer 
resin modifier, a plasticizer (e.g. for unsaturated polyesters) and an intermediate in 
the manufacture of pesticides and other chemicals.28-30 It is used as an industrial 
catalyst (in acetic anhydride synthesis) and as a solvent (e.g. cellulose acetate), a 
stabilizer for peroxides, and a strength agent for rubber and plastics including vinyl 
polymers and unsaturated polyesters.28-30 Previously, we have detected a range of 
phosphate chemicals including triethyl phosphate, tris(chloropropyl) phosphate, 
tris(dichloropropyl) phosphate in wastewater samples from Beenyup WWTP.  
Furthermore, while all phosphate chemicals were below detection in samples 
collected post-RO treatment (LOD = 100 ng/L), they were all detected in the RO 
reject water.11 Further research is needed to better understand the occurrence of 
triethyl phosphate in wastewater and assess the rejection of this class of chemicals 
during UF/RO treatment. However, given the small molecular weight, the high pKa 
and the low log Kow (see Table S5) a poor rejection is expected for this compound.
7 
Out of 79 pesticides, 51 pesticides metabolites, 9 biocides and 2 biocides 
metabolites targeted, only 2 pesticides (metolachlor and prosulfocarb) and 1 biocide 
(propiconazole) were detected at very low concentrations in RO treated water. 
Interestingly, the pesticide metolachlor was also detected in our previous work,10 at 
similar concentrations, possibly indicating breakthrough during RO treatment. 
However, in this study metolachlor was detected in 100% of the samples tested (4 
RO treated samples and 4 UV treated samples, see Table 1) compared to only 3% 
of the samples (1 sample out of 33 analysed) tested previously.10 The high frequency 
in the detection observed for metolachlor in this work may be due to the much lower 
LOD (1 ng/L) achieved in this study compared to the LOD (60 ng/L) achieved in the 
previous study. Propiconazole, the biocide detected in this work, was not detected 
previously,10 again possibly because the LOD (5 ng/L) achieved in this study was 
much lower  than the LOD (100 ng/L achieved in the previous study. Prosulfocarb 
was not analysed previously and therefore a comparison is not possible. All three 
pesticides have MW that is greater than the MWCO of the RO membranes and also 
possess log Kow > 2. In this scenario, good removal is expected, although membrane 
breakthrough could be caused by partitioning/diffusion within the membrane.7 
Only 3 pharmaceuticals of the 88 pharmaceuticals and 27 pharmaceutical 
metabolites (27 compounds) tested were detected in RO treated water. Lamotrigine 
is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder.31 It 
is also used off-label as an adjunct in treating depression. Tramadol is used similarly 
to codeine and it is a synthetic analgesic used to treat moderate to moderately-
severe pain. The drug has a wide range of applications, including treatment of 
rheumatoid arthritis, restless legs syndrome and fibromyalgia.32 Metformin is very 
commonly used for treatment of type 2 diabetes in obese and overweight people and 
it is listed as one (of only two) oral antidiabetics in the World Health Organization 
Model List of Essential Medicines.33 All 3 pharmaceuticals are registered for use and 
commonly sold in Australia.34 Concentration of lamotrigine and tramadol in RO 
treated water were below 5 ng/L, with the exception of tramadol, which was 
measured at 475 ng/L in one sample (19/01/2012). The reason for such high 
concentration post RO treatment is not known. However, given that contamination 
from this compound (100 ng/L) was also seen in one laboratory blank, this single 
high detection level should be treated as an outlier. In contrast the median 
concentration of metformin over all RO treated water samples was 99 ng/L. 
Metformin, is commonly found in water bodies due to its high volume usage.35 
Moreover, given its relatively low molecular weight and high solubility (see Table S5), 
RO rejection is expected to be relatively poor. All 3 pharmaceuticals have been 
previously tested in Beenyup WWTP and Beenyup AWRP but were not detected in 
RO treated water possibly due to higher LOD.11 
The 3 artificial sweeteners detected in RO treated water were acesulfame, sucralose 
and saccharin. While the presence of artificial sweeteners, a common constituent of 
low calorie food and beverages, in the aquatic environment has been reported in 
previous studies overseas,36-43 little has been reported regarding their presence 
within Australian waters.11 Recent studies have shown that artificial sweeteners are 
quite stable and persistent in the environment, and are excreted predominantly 
unchanged as waste from the body.36,39,40 Sucralose in particular, is resistant 
towards biodegradation, and as a result is persistent in WWTP.36,37,43 To the best of 
our knowledge, little has been reported regarding the behavior of artificial 
sweeteners during RO treatment. Acesulfame (MW = 162 Da) and saccharin (MW = 
183 Da) both have molecular weights close to the MWCO of the RO membrane. 
Moreover both have high water solubility,42,44,45 meaning they are unlikely to adsorb 
on membranes and therefore poor rejection is expected7 (see Table S5). 
Furthermore, the presence of  µg/L concentrations in secondary WW feed to 
Beenyup AWRP may also play an important role in the detection of these 
sweeteners post RO treatment, as high  concentrations in secondary WW have been 
linked to detection in RO treated water, even when RO rejection is high.10 Artificial 
sweeteners represent an ideal marker for wastewater contamination and the study of 
their behavior during RO treatment could significantly aid wastewater recycling and 
future management of groundwater replenishment. 
 
3.2 Compounds detected in UV treated water  
At Beenyup AWRP, the last treatment barrier is UV for pathogen inactivation. This 
barrier employs ITT Wedeco units (low pressure lamps, UV-C at 254nm, 4 UV units 
in series, dose of up to 50mJ/cm2 for each unit). Analysis of samples post-UV 
treatment showed that the concentration of some UV degradable compounds was 
reduced. Table 1 presents the concentration of chemicals detected in UV treated 
water as well the observed average removal after the UV treatment, calculated using 
the percentage difference in concentration between RO treated water and UV 
treated water for matched samples. 
 
For both benzotriazole and 4+5-Methyl-1H-benzotriazole the UV treatment led to 
average removal of about 50% of the initial concentrations. This is in agreement with 
previous research showing benzotriazoles are prone to degradation by UV light 
(direct photolysis); benzotriazole and its derivatives are known UV absorbers,46,47 so 
degradation and reactivity of this class of chemicals was expected to be significant. 
For galaxolidone, a moderate but highly variable removal was achieved (average UV 
removal = 37±48%). A significant and consistent reduction of the concentration of the 
artificial sweeteners acesulfame (average UV removal: 95±2%) was also observed. 
The kinetic and the mechanism of degradation of this compound has previously been 
described in full,48 confirming the effectiveness of UV treatment to reduce the 
concentration of this compound in receiving waters. For triethyl phosphate the 
median UV removal was 50%. For the remaining compounds detected in RO treated 
water, it was not always clear whether UV treatment reduced concentrations in the 
final product water as most concentrations were low and near the LOQ of the 
compound or in some case, the concentration detected post UV was higher than the 
concentration detected post RO. 
Tertiary treatments such as UV for virus inactivation, as well as advanced oxidation 
processes including use of strong oxidants such as ozone, H2O2 + UV and 
combination of them, usually result in the incomplete mineralisation of 
micropollutants, and the formation of mixtures of transformation by-products.49-51 The 
chemical structures, but more importantly the toxicological properties, of the 
transformation by-products arising from incomplete oxidation of micropollutants 
remains unknown for a wide range of chemicals although research in this area has 
been rapidly developing in the last decade.49-52 Nowadays, there is general 
consensus that whenever an oxidation process is applied to polish the final water, 
transformation by-products should be also assessed through non-target analysis and 
included in the risk assessment where possible. Further research into the integrated 
use of target/non-target chemical screening and bioassays as a monitoring tool for 
water recycling is recommended.  
 
3.3 Contribution of anthropogenic chemicals to the dissolved organic carbon 
Previous research characterized RO water in Perth, Western Australia for 375 
anthropogenic chemicals, with 108 chemicals detected on at least one occasion, and 
30 chemicals detected in more than 25% of all samples.5,10 However, assessment of 
the contribution of these detected chemicals to the DOC measured in RO treated 
water was only able to attribute 2.5 to 5% of the DOC to anthropogenic chemicals.10 
One of the objectives of this present work was to assess whether analysis of an 
extended list of polar organic chemicals could help to account for the remaining 
DOC. In this study, the RO treated water was analysed for 291 chemicals, of which 
248 chemicals have not been analysed previously at Beenyup AWRP. Out of these 
291 chemicals, only 13 compounds (~4.5%) were detected. The contribution of 
anthropogenic chemicals to the residual DOC in post UV treated water was 
estimated using the same methodology described in Linge et al., in which DOC 
contribution is calculated using the percentage carbon in each detected molecule.10 
Overall, the detection of these 13 compounds in the RO effluent could not account 
for the residual DOC in RO water, with the detected chemicals contributing between 
0.6 µg/L (median value) to 1.3 µg/L (maximum value) of DOC. The DOC measured 
at Beenyup AWRP plant over the 4 days of sampling (16/01/12 - 19/01/12) averaged 
58 µg/L and therefore, the total contribution of DOC from these anthropogenic 
chemicals remains very small (1.0 – 2.3%).  
3.4 Screening Health Risk Assessment 
A screening health risk assessment was conducted using the concept of the risk 
quotient (RQ), which is calculated as the ratio between the reported concentration of 
each chemical and the appropriate health values.5,10 Median and maximum 
concentrations of chemicals detected in post UV treated water were used to 
generate median and maximum RQs (Table 2). A risk quotient below one implies no 
health impact is expected. Health values for benzotriazole, metolachlor and 
metformin were taken from the Australian Guidelines for Water Recycling,53 while a 
health value for propiconazole was taken from the Australian Drinking Water 
Guidelines.54 The health value for tolyltriazoles (4+5-Methyl-1H-benzotriazole) is the 
value used for recycled water at Beenyup AWRP.55 No Australian derived water 
guidelines exist for the other chemicals detected in this study and therefore other 
approaches were used to determine health values. For the metabolite galaxolidone, 
the AGWR guideline for the parent compound galaxolide (1750 μg/L) was used, with 
the addition of an extra safety factor of ten.53 For triethyl phosphate, a health value of 
1000 µg/L was used, as it belongs to the same class of phosphate flame retardants, 
including tri(dichlorisopropyl) phosphate, triphenyl phosphate; tris(2 
chloroethyl)phosphate.53 For the pharmaceuticals lamotrigine and tramadol, health 
values were calculated from the lowest daily therapeutic dose (LDTD)56 using the 
approach outlined in the Australian Guidelines for Water Recycling:53 
 
Health value (μg/L) = (LDTD (mg/day) × P × 103) / (SF × V (L/day))    (1) 
 
 
where P = proportion of LDTD estimated to come from drinking water (100%); 103 = 
unit conversion mg/L to μg/L; SF: safety factor (1000 for most pharmaceuticals); V = 
volume of water drunk (2 L/day). Health values for the artificial sweeteners, 
acesulfame, saccharine and sucralose,44 and the pesticide prosulfocarb57 were all 
derived from acceptable daily intake values (ADI, expressed as mg/kg body weight, 
assuming body weight = 70 kg) as outlined in the Australian Guidelines for Water 
Recycling.53 
 
Table 2. Screening health risk assessment for UV treated water reporting 





RQmed RQmax Reference 
4+5-Methyl-1H-
benzotriazole 
20 0.019 0.020 55  
Benzotriazole 20 0.021 0.028 53  
Galaxolidone 175a 0.000008 0.00002 53  
Lamotrigine 12.5b 0.0002 0.0004 56  
Metolachlor 300 0.000008 0.00002 53  
Metformin 250 0.0004 0.0004 53  
Propiconazole 100 0.00006 0.000075 54  
Prosulfocarb 0.175c 0.028 0.028 57  
Tramadol 200b N/A 0.0000125 56  
Acesulfame 315c N/A 0.0000079 44  
Saccharin 133c 0.000037 0.000037 44  
Sucralose 525c 0.000016 0.000019 44  
Triethyl phosphate 1000d 0.0001 0.0001 53  
a
Galaxolidone, a metabolite of galaxolide, currently does not have a guideline value. The drinking 
water guideline for galaxolide (1750 µg/L) was used instead with an extra safety factor of ten. 
b
Drinking water guideline calculated from the lowest daily therapeutic dose (LDTD). 
c
Drinking water 
guideline calculated from the acceptable daily intake (ADI). 
d
Drinking water guideline derived from 
similar phosphate flame retardants. 
 
For all chemicals both RQmed and RQmax were between 2 and 6 orders of magnitude 
below 1 implying a high degree of safety associated with human consumption of 
recycled water.  
 
4. Conclusions  
The target screening conducted in RO and UV treated water samples from Beenyup 
AWRP has shown the presence of small (MW<200 Da), hydrophilic species such as 
corrosion inhibitors (i.e. benzotriazole and 4+5-Methyl-1H-benzotriazole), 
pharmaceuticals (i.e. metformin), artificial sweeteners (i.e. acesulfame and 
saccharin) and industrial chemicals (i.e. triethyl phosphate). These chemicals were 
consistently found in all samples and could potentially be used as treatment 
performance indicators in future studies. Very low concentrations (ng/L) of pesticides 
(metolachlor, propiconazole and prosulfocarb), along with other pharmaceuticals 
(lamotrigine and tramadol) were also detected. The break-through during RO 
treatment of some of these relatively large (MW >250 Da) and hydrophobic (log Kow 
> 2) chemicals could be due to diffusion/partitioning within the membrane. The UV 
treatment installed at Beenyup AWRP helped to reduced UV degradable compounds 
such as the corrosion inhibitors (>50% removal), the flame retardant triethyl 
phosphate (~50% removal) and the artificial sweetener acesulfame (~95% removal).  
Overall, the contribution of the detected anthropogenic chemicals to the DOC 
measured in post UV treated water was found to be minimal (1.0 – 2.3%). The target 
screening analysis also show that a number of anthropogenic chemicals (i.e. 278 out 
of 291 compounds, >95.5%) such as pesticides, biocides, industrial chemicals, 
pharmaceuticals and metabolites were not detectable in RO and UV treated water. A 
screening heath risk assessment showed that RQ were generally 2 to 6 orders of 
magnitude below 1, implying a high degree of safety associated with human 
consumption of recycled water.  Overall this chemical screening provides further 
evidence of the overall safety of the use of recycled wastewater treated by RO and 
UV as a potable water source, and it has confirmed that anthropogenic chemicals 
constitute a relatively small percentage of DOC in RO treated WW. However, the 
study also highlights the limitations of the traditional approach for assessing 
chemical safety, focused on end-product compliance testing for all potential 
chemicals. This approach is time consuming, expensive, and relies on the availability 
of appropriate health values for all chemicals tested.  Given the time consuming 
nature of trace chemical analysis, further research into the use of bioassays as a 
monitoring tool for water recycling is recommended.11,58-61 Bioanalytical tools can 
screen for a wide range of contaminants and transformation products, based on 
biological effect, rather than monitoring specific chemicals, and may provide an 
efficient high-throughput tool broad screen assessment of water quality or hazard 
identification, and risk characterisation.  
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Figure 1. Parents compounds, transformation products and metabolites assessed in 
the target screening analysis. 
 
Figure 2. Schematic of Beenyup Wastewater Treatment Plant (WWTP) and 
Beenyup Advanced Water Recycling Plant (AWRP). Sampling points (i.e. 1-2) are 
also indicated. UF: ultrafiltration; RO: reverse osmosis; UV: UV disinfection; ML/d: 
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Table S1. Summary of the chemicals targeted in post RO and post UV treated water at Beenyup AWRP. 











C6) 94-75-7 C8H6Cl2O3 219.9689 - 5 herbicide 
Acetochlor 34256-82-1 C14H20ClNO2 269.1177 + 100 herbicide 
Alachlor (Alachlor-d13) 15972-60-8 C14H20ClNO2 269.1177 + 100 herbicide 
Aldicarb (Aldicarb-d3) 116-06-3 C7H14O2N2S 190.0776 + 10 insecticide 
Asulam 3337-71-1 C8H10N2O4S 230.0356 + 20 herbicide 
Atraton 1610-17-9 C9H17N5O 211.1428 + 1 herbicide 
Atrazine (Atrazine-d5) 1912-24-9 C8H14Cl1N5 215.0932 + 1 herbicide 
Azoxystrobin 131860-33-8 C22H17N3O5 403.1163 + 1 fungicide 
Bentazone (Bentazone-d6) 25057-89-0 C10H12N2O3S 240.0563 - 0.5 herbicide 
Bromazil 314-40-9 C9H13BrN2O2 260.0155 + 3 herbicide 
Bromoxynil 1689-84-5 C7H3Br2NO 276.8561 - 1 herbicide 
Carbetamide 16118-49-3 C12H16N2O3 236.1155 - 1 herbicide 
Chloridazon (Chloridazon-d5) 1698-60-8 C10H8Cl1N3O 221.035 + 2 herbicide 
Chlortoluron (Chlorotoluron-d6) 15545-48-9 C10H13ClN2O 212.0711 + 0.5 herbicide 
Clomazone 81777-89-1 C12H14ClNO2 239.0708 + 1 herbicide 
Cymoxanil 57966-95-7 C7H10N4O3 198.0753 + 10 fungicide 
Cyproconazole 94361-06-5 C15H18ClN3O 291.1133 + 10 fungicide 
Cyprodinil 121552-61-2 C14H15N3 225.126 + 10 fungicide 
Desmedipham 13684-56-5 C16H16N2O4 300.1105 + 20 herbicide 
Diazinon (hydrolized)(Diazinon-d10) 333-41-5 C12H21N2O3PS 304.1005 + n.q. insecticide 
Dicamba (Dicamba-d3) 1918-00-9 C8H6Cl2O3 219.9699 - 20 herbicide 
Dichlorprop (Dichlorprop-d6) 120-36-5 C9H8O3Cl2 233.9845 - 5 herbicide 
Diflufenican (Diflufenican-d3) 83164-33-4 C19H11F5N2O2 394.0735 + 70 herbicide 
Dimethachlor 50563-36-5 C13H18ClNO2 255.1021 + 0.5 herbicide 
Dimethenamid 87674-68-8 C12H18ClNO2S 275.0741 + 0.5 herbicide 
Dinoseb 88-85-7 C10H12N2O5 240.0741 - 5 herbicide 
Epoxyconazole 133855-98-8 C17H13ClFN3O 329.0726 + 10 fungicide 
Ethofumesat 26225-79-6 C13H18O5S 286.0869 + 10 herbicide 
Fenpropimorph 67306-03-0 C20H33NO 303.2557 + 1 fungicide 
Fipronil 120068-37-3 C12H4Cl2F6N4O1S 435.9387 + 1 insecticide 
Fluazifop (free acid) 69335-91-7 C15H12F3NO4 327.0724 - 1 herbicide 
Fludioxonil 131341-86-1 C12H6F2N2O2 248.0392 - 0.5 fungicide 
Flufenacet 142459-58-3 C14H13F4N3O2S 363.067 + 2.5 herbicide 
Fluroxypyr (free acid) 69377-81-7 C7H5Cl2FN2O3 253.9667 - 5 herbicide 
Flusilazole 85509-19-9 C16H15F2N3Si 315.0998 + 15 fungicide 
Foramsulfuron 173159-57-4 C17H20N6O7S 452.1114 + 10 herbicide 
Hexazinon 51235-04-2 C12H20N4O2 252.1581 + 0.5 herbicide 
Imidacloprid 138261-41-3 C9H10ClN5O2 255.0523 + 3 insecticide 
Ioxynil 1689-83-4 C7H3I2NO 370.8299 - 5 herbicide 
Isoproturon (Isoproturon-d6) 34123-59-6 C12H18N2O 206.1414 + 0.5 herbicide 
Kresoxim-methyl 143390-89-0 C18H19NO4 313.1309 + 2.5 fungicide 
Linuron 330-55-2 C9H10Cl2N2O2 248.0114 + 2.5 herbicide 
MCPA (MCPA-d6) 94-74-6 C9H9ClO3 200.0235 - 1 herbicide 
MCPB 94-81-5 C11H13ClO3 228.0553 - 10 herbicide 
Mecoprop (Mecoprop-d6) 93-65-2 C10H11ClO3 214.0391 - 1 herbicide 
Mesotrione (Mesotrione-d3) 104206-82-8 C14H13NO7S 339.0407 - 25 herbicide 
Metalaxyl 57837-19-1 C15H21NO4 279.1465 + 2.5 fungicide 
Metamitron 41394-05-2 C10H10N4O 202.086 + 25 herbicide 
Metazachlor 67129-08-2 C14H16ClN3O 277.0976 + 1 herbicide 
Metolachlor  (Metolachlor-d6) 51218-45-2 C15H22ClNO2 283.1334 + 0.5 herbicide 
Metribuzin 21087-64-9 C8H14N4OS 214.0883 + 5 herbicide 
Metsulfuron-methyl 74223-64-6 C14H15N5O6S 381.0738 + 3 herbicide 
Monuron 150-68-5 C9H11ClN2O 198.0554 + 0.5 herbicide 
Napropamid 15299-99-7 C17H21NO2 271.1567 + 0.5 herbicide 
Nicosulfuron 111991-09-4 C15H18N6O6S 410.1003 + 5 herbicide 
Orbencarb 34622-58-7 C12H16ClNOS 257.0647 + 10 herbicide 
Pethoxamid 106700-29-2 C16H22ClNO2 295.1334 + 1 herbicide 
Phenmedipham 13684-63-4 C16H16N2O4 300.1116 + 25 herbicide 
Pirimicarb 23103-98-2 C11H18N4O2 238.143 + 1 insecticide 
Prochloraz 67747-09-5 C15H16Cl3N3O2 375.0303 + 200 fungicide 
Prometon 1610-18-0 C10H19N5O 225.1584 + 0.5 herbicide 
Propachlor 1918-16-7 C11H14ClNO 211.0758 + 0.5 herbicide 
Propaquizafop 111479-05-1 C22H22ClN3O5 443.1242 + 100 herbicide 
Prosulfocarb  (Surrogate: Propiconazole-d5) 52888-80-9 C14H21NOS 251.1349 + 5 herbicide 
Pyraclostrobin 175013-18-0 C19H18ClN3O4 387.0986 + 7.5 fungicide 
Pyrimethanil 53112-28-0 C12H13N3 199.1109 + 1 fungicide 
Rimsulfuron 122931-48-0 C14H17N5O7S2 431.0564 + 25 herbicide 
Simazine (Simazine-d5) 122-34-9 C7H12ClN5 201.0776 + 1 herbicide 
Simeton 673-04-1 C8H15N5O 197.1271 + 0.25 herbicide 
Spiroxamine 118134-30-8 C18H35N1O2 297.2668 + 2.5 fungicide 
Sulcotrione (Sulcotrione-d3) 99105-77-8 C14H13Cl1O5S 328.0167 + 20 herbicide 
Tebuconazole 107534-96-3 C16H22ClN3O 307.1446 + 15 fungicide 
Tebutam (Tebutam-d4) 35256-85-0 C15H23NO 233.1774 + 2.5 herbicide 
Terbumeton 33693-04-8 C10H19N5O 225.1584 + 0.5 herbicide 
Terbutylazine (Terbutylazine-d5) 5915-41-3 C9H16ClN5 229.1089 + 2 herbicide 
Thifensulfuron-methyl 79277-27-3 C12H13N5O6S2 387.0302 - 5 herbicide 
Trinexapac-ethyl 95266-40-3 C13H16O5 252.0992 + 3 growth regulator 
Tritosulfuron 142469-14-5 C13H9F6N5O4S 445.0279 + 5 herbicide 
PESTICIDE METABOLITES 
2,4-dimethylphenylformamide 60397-77-5 C9H11NO 149.0835 + 20 Amitraz 
2,6-Dichlorbenzamide 2008-58-4 C7H5Cl2NO 188.9743 + 3 Dichlobenil 
2-Amino-4-methoxy-6-methyl-1,3,5 triazine 1668-54-8 C5H8N4O 140.0693 + 2.5 
Thifensulfuron-methyl 
Metsulfuron-methyl 
3,5,6-Trichloro-2-pyridinole 6515-38-4 C5H2Cl3NO 196.9202 - 1 Chlorpyrifos 
3,5-dibromo-4-hydroxybenzoic acid 3337-62-0 C7H4Br2O3 293.8533 - 2 Bromoxynil 
3-Phenoxybenzoic acid 3739-38-6 C13H10O3 214.0624 - 5 Permethrin 
Acetochlor-ESA 187022-11-3 C14H21NO5S 315.1135 - 1 Acetochlor 
Acetochlor-OXA 194992-44-4 C14H19NO4 265.132 - 1 Acetochlor 
Alachlor-ESA 142363-53-9 C14H21NO5S 315.1135 - 1 Alachlor 
Alachlor-OXA 171262-17-2 C14H19NO4 265.132 - 1 Alachlor 
Atrazin-Desethyl (Atrazin-desethyl-15N3) 6190-65-4 C6H10ClN5 187.0619 + 2.5 Atrazine 
Atrazin-Desisopropyl (Atrazine-desisopropyl-d5) 1007-28-9 C5H8ClN5 173.0463 + 5 Atrazine 
Atrazine-2-Hydroxy (Atrazine-2-Hydroxy-d5) 2163-68-0 C8H15N5O 197.1271 + 1 Atrazine 
Atrazine-desethyl-2-hydroxy  19988-24-0 C6H11N5O 169.0958 + 2 Prometon/Atrazine 
Azoxystrobinic acid N/A C21H15N3O5 389.1012 + 3 Azoxystrobin 
Bifenoic acid 53774-07-5 C13H7Cl2NO5 326.9707 - 1 Bifenox 
Chloridazon-desphenyl (Chloridazon-desphenyl-
15
N2) 6339-19-1 C4H4ClN3O 145.0047 + 200 Chloridazon 
Chloridazon-methyl-desphenyl 17254-80-7 C5H6ClN3O 159.0199 + 0.5 Chloridazon 
Dimethachlor-ESA N/A C13H19NO5S 301.0978 - 1 Dimethachlor 
Dimethachlor-OXA 1086384-49-7 C13H17NO4 251.1158 - 5 Dimethachlor 
Dimethenamide-ESA 205939-58-8 C12H19N1O5S2 321.0699 - 1 Dimethenamide 
Dimethenamide-OXA 380412-59-9 C12H17NO4S 271.0873 - 1 Dimethenamide 
N,N-Dimethylaminosulfanilid (DMSA) 4710-17-2 C8H12N2O2S 200.0614 + 1.5 Dichlofluanid 
Fipronil-sulfide 120067-83-6 C12H4Cl2F6N4S 419.9438 - 1 Fipronil 
Fipronil-sulfon 120068-36-2 C12H4Cl2F6N4O2S 451.9336 - 2.5 Fipronil 
Flufenacet-ESA 201668-32-8 C11H14FNO4S 275.0622 - 1 Flufenacet 
Flufenacet-OXA 201668-31-7 C11H12FNO3 225.0796 - 1 Flufenacet 
Isoproturon-didemethyl 56046-17-4 C10H14N2O 178.1101 + 1 Isoproturon 
Isoproturon-monodemethyl 34123-57-4 C11H16N2O 192.1257 + 1 Isoproturon 
Mesotrione-MNBA 110964-79-9 C8H7NO6S 244.9989 - 75 Mesotrion 
Metamitron-Desamino 36993-94-9 C10H9N3O 187.0746 + 1.5 Metamitron 
Metazachlor-ESA 172960-62-2 C14H17N3O4S 323.0934 - 5 Metazachlor 
Metazachlor-OXA N/A C14H15N3O3 273.1108 - 5 Metazachlor 
Metolachlor-ESA 171118-09-5 C15H23NO5S 329.1291 - 1 Metolachlor 
Metolachlor-Morpholinon 120375-14-6 C14H19NO2 233.141 + 1 Metolachlor 
Metolachlor-OXA 152019-73-3 C15H21NO4 279.1465 - 1.5 Metolachlor 
Metribuzin-Desamino 35045-02-4 C8H13N3OS 199.0774 + 0.5 Metribuzin 
Metribuzin-Diketo 56507-37-0 C7H12N4O2 184.0966 + 25 Metribuzin 
N-(2,4-dimethylphenyl)-N-methylformamidin 33089-74-6 C10H14N2 162.1152 + 5 Amitraz 
N,N-dimethyl-N'-(4-methylphenyl)-sulfamid 66840-71-9 C9H14N2O2S 214.077 + 0.5 Tolyfluanid 
Propachlor-ESA 123732-85-4 C11H15NO4S 257.0716 - 1 Propachlor 
Propachlor-OXA 70628-36-3 C11H13N1O3 207.089 - 3 Propachlor 
Propazine-2-hydroxy 7374-53-0 C9H17N5O 211.1428 + 5 Propazine 
Pyrimidinole 2814-20-2 C8H12N2O 152.095 + 30 Diazinon 
Simazine-2-hydroxy 2599-11-3 C7H13N5O 183.1115 + 1 Simazine 
Sulcotrione-CMBA 53250-83-2 C8H7Cl1O4S 233.9748 - 20 Sulcotrione 
Terbutylazine-2-hydroxy 66753-07-9 C9H17N5O 211.1428 + 5 Terbutylazine 
Terbutylazine-desethyl 30125-63-4 C7H12Cl1N5 201.0776 + 0.5 Terbutylazine 
Terbutylazine-desethyl-2-hydroxy 30125-63-4 C7H13N5O 183.1115 + 1 Terbutylazine 
PHARMACEUTICALS 
4-Dimethylaminoantipyrine 58-15-1 C13H17N3O 231.1366 + 5 
 Albuterol 18559-94-9 C13H21NO3 239.1521 + 2 
 Amisulpride (Amisulpride-d5) 71675-85-9 C17H27N3O4S 369.1722 + 0.5 
 Amitriptylin 50-48-6 C20H23N 277.183 + 2 
 
Atenolol (Atenolol-d7) 29122-68-7 C14H22N2O3 266.1625 + 1 
 Atomoxetine (Atomoxetine-d3) 83015-26-3 C17H21NO 255.1623 + 1 
 Atorvastatine 134523-03-8 C33H35FN2O5 558.253 + 50 
 Azithromycin (Azithromycin-d3) 83905-01-5 C38H72N2O12 748.508 + 2.5 
 Bezafibrate (Bezafibrate-d4) 41859-67-0 C19H20ClNO4 361.1075 + 2.5 
 Bicalutamide 90357-06-5 C18H14F4N2O4S 430.061 - 10 
 Bupropion 34911-55-2 C13H18ClNO 239.1077 + 1 
 Candesartan 139481-59-7 C24H20N6O3 440.1597 + 10 
 Carbamazepine (Carbamazepine-
13
C, d2) 298-46-4 C15H12N2O 236.0944 + 1 
 Cetrizine 83881-52-1 C21H25ClN2O3 388.1554 + 15 
 Cilastatin 82009-34-5 C16H26N2O5S 358.1562 + n.q. 
 Citalopram (Citalopram-d6) 59729-33-8 C20H21FN2O 324.1638 + 1 
 Clarithromycin (Clarithromycin-d3) 81103-11-9 C38H69NO13 747.4763 + 5 
 Clindamycin 18323-44-9 C18H33ClN2O5S 424.1798 + 5 
 Clopidogrel (Clopidogrel-d4) 144457-28-3 C15H14ClNO2S 307.0439 + 5 
 Clozapine (Clozapine-d8) 5786-21-0 C18H19ClN4 326.1298 + 10 
 Cyclophosphamide (Cyclophosphamide-d4) 50-18-0 C7H15Cl2N2O2P 260.0248 + 10 
 Cytarabine 147-94-4 C9H13N3O5 243.085 + 10 
 Dexamethasone 50-02-2 C22H29FO5 392.1999 + 5 
 Dextromethorphan 125-71-3 C18H25NO 271.1936 + 2.5 
 Diclofenac (Diclofenac-d4) 15307-86-5 C14H11Cl2NO2 295.0161 + 5 
 Dronedarone 141626-36-0 C31H44N2O5S 556.2971 + n.q. 
 Ephedrine 299-42-3 C10H15NO 165.2345 + 2 
 Eprosartan (Eprosartan-d3) 133040-01-4 C23H24N2O4S 424.1457 + 5 
 Ethambutole 1070-11-7 C10H24N2O2 204.1838 + n.q. 
 Exemestane 107868-30-4 C20H24O2 296.1771 + 1 
 Fenofibrate (Fenofibrate-d6) 49562-28-9 C20H21Cl1O4 360.1123 + 100 
 FK-506 (Tacrolimus) 104987-11-3 C44H69NO12 803.482 - 50 
 Fluconazole (Fluconazole-d4) 86386-73-4 C13H12F2N6O 306.1035 + 10 
 Fluoxetine (Fluoxetine-d5) 54910-89-3 C17H18F3NO 309.1335 + 2 
 Furosemide (Furosemide-d5) 54-31-9 C12H11ClN2O5S 330.0077 - 30 
 Gabapentin (Gabapentin-d4) 60142-96-3 C9H17NO2 171.1259 + 50 
 Gemcitabine (Gemcitabine-
13
C, d2) 95058-81-4 C9H11F2N3O4 263.0718 + 50 
 Hydrochlorothiazide 58-93-5 C7H8ClN3O4S2 296.9645 - 10 
 Ibuprofen (Ibuprofen-d3) 15687-27-1 C13H18O2 206.1301 + 25 
 
Ifosfamide 3778-73-2 C7H15Cl2N2O2P 260.0248 + 3 
 Indomethacin (Indomethacin-d4) 53-86-1 C19H16ClNO4 357.0768 + 10 
 Iobitridol 136949-58-1 C20H28I3N3O9 834.896 + 2000 
 Iohexol 66108-95-0 C19H26I3N3O9 820.8798 + 1000 
 Iopromide 73334-07-3 C18H24I3N3O8 790.8692 + 100 
 Ketamine 6740-88-1 C13H16ClNO 237.092 + 0.5 
 Ketoprofen 22071-15-4 C16H14O3 254.0937 + 25 
 Lamotrigine (Surrogate: Atrazine-desethyl-d5) 84057-84-1 C9H7Cl2N5 255.0079 + 1 
 Levamisole 14769-73-4 C11H12N2S 204.0721 + 2.5 
 Levetiracetam (Levetiracetam-d3) 102767-28-2 C8H14N2O2 170.1055 + 5 
 Lidocaine (Lidocaine-d10) 137-58-6 C14H22N2O 234.1732 + 1.5 
 Mefenamic acid (Mefenamic acid-d3) 61-68-7 C15H15NO2 241.1097 + 2.5 
 Metformin (Metformin-d6) 657-24-9 C4H11N5 129.1014 + 20 
 Methylprednisolone (Methylprednisolone-d4) 83-43-2 C22H30O5 374.2093 + 5 
 Metoclopramide 7232-21-5 C14H22ClN3O2 299.1401 + 1 
 Metoprolol (Metoprolol-d7) 37350-58-6 C15H25NO3 267.1829 + 1 
 Metronidazole 443-48-1 C6H9N3O3 171.0638 + 5 
 Moclobemide 71320-77-9 C13H17ClN2O2 268.0979 + 1 
 Mycophenolic acid 24280-93-1 C17H20O6 320.126 + 10 
 Naltrexon 16590-41-3 C20H23NO4 341.1627 + 1 
 Naproxen (Naproxen-d3) 22204-53-1 C14H14O3 230.0937 + 10 
 Oseltamivir 196618-13-0 C16H28N2O4 312.2044 + 2.5 
 Paracetamol (Paracetamol-d4) 103-90-2 C8H9NO2 151.0628 + 10 
 Phenazone (Phenazone-d3 60-80-0 C11H12N2O 188.0944 + 0.5 
 Pravastatin (Pravastatin-d3) 81093-37-0 C23H36O7 424.2461 - 20 
 Prednisolon 50-24-8 C21H28O5 360.1937 + 15 
 Primidone (Primidone-d5) 125-33-7 C12H14N2O2 218.105 + 5 
 Propranolol (Propranolol-d7) 525-66-6 C16H21NO2 259.1567 + 0.5 
 Ranitidine (Ranitidine-d6) 66357-35-5 C13H22N4O3S 314.1407 + 5 
 Ritonavir (Ritonavir-d6) 155213-67-5 C37H48N6O5S2 720.3128 + 10 
 Rosuvastatin 287714-41-4 C22H28FN3O6S 481.1683 + 5 
 Roxithromycin 80214-83-1 C41H76N2O15 836.524 + 5 
 Sitagliptin 486460-32-6 C16H15F6N5O 407.1181 + 10 
 Sotalol (Sotalol-d6) 3930-20-9 C12H20N2O3S 272.1189 + 5 
 Sulfadiazine (Sulfadiazine-d4) 68-35-9 C10H10N4O2S 250.0519 + 5 
 
Sulfadimethoxine (Sulfadimethoxine-d4) 122-11-2 C12H14N4O4S 310.073 + 2.5 
 Sulfamethazine (Sulfamethazine-
13
C6) 57-68-1 C12H14N4O2S 278.0832 + 3 
 Sulfamethoxazole (Sulfamethoxazole-d4) 723-46-6 C10H11N3O3S 253.0516 + 5 
 Sulfapyridine (Sulfapyridine-d4) 144-83-2 C11H11N3O2S 249.0566 + 5 
 Sulfathiazole (Sulfathiazole-d4) 72-14-0 C9H9N3O2S2 255.0131 + 5 
 Telmisartan 144701-48-4 C33H30N4O2 514.2369 + 100 
 Thiopental 76-75-5 C11H18N2O2S 242.1089 - 15 
 Tramadol (Tramadol-d6) 27203-92-5 C16H25NO2 263.1885 + 1 
 Trimethoprim (Trimethoprim-d9) 738-70-5 C14H18N4O3 290.1373 + 2 
 Trimipramin 739-71-9 C20H26N2 294.2096 + 1 





C5) 137862-53-4 C24H29N5O3 435.227 + 5 
 Venlafaxine (Venlafaxine-d6) 93413-69-5 C17H27NO2 277.2036 + 0.5 
 Verapamil (Verapamil-d6) 152-11-4 C27H38N2O4 454.2826 + 2   
PHARMACEUTICAL METABOLITES 
2',3'-di-O-acetyl-5'-desoxy-5-fluorocytidine 161599-46-8 C13H16FN3O6 329.1023 + 10 Capecitabin 
4-(Trifluoromethyl)phenol 402-45-9 C7H5F3O 162.0287 - 50 Fluoxetin 
4-Acetamidoantipyrine 83-15-8 C13H15N3O2 245.117 + 1 Aminopyrine/Metamizol 
4-Formylaminoantipyrine 1672-58-8 C12H13N3O2 231.1008 + 1.5 Aminopyrine/Metamizol 
AMDOPH 519-65-3 C13H17N3O3 263.127 + 0.5 Aminopyrine 
Atenolol-desisopropyl 81346-71-6 C11H16N2O3 224.1161 + 50 Atenolol 
Atenololic acid (Atenolol acid–d5) 56392-14-4 C14H21N1O4 267.1465 + 1 Atenolol/Metoprolol 




C, d2) 36507-30-9 C15H12N2O2 252.0899 + 1 Carbamazepine 
Clofibric acid (Clofibric acid-d4) 882-09-7 C10H11ClO3 214.0391 - 1 Clofibrate 
D617 34245-14-2 C17H26N2O2 290.1994 + 0.5 Verapamil 
Fenofibrinic acid 42017-89-0 C17H15ClO4 318.0653 + 2.5 Fenofibrate 
Iminostilbene 256-96-2 C14H11N 193.0892 + 
 
Carbamazepine 
N,N-Didesvenlafaxine 93413-77-5 C15H23N1O2 249.1729 + 5 Venlafaxine 
N,O-Didesvenlafaxine 135308-74-6 C15H23N1O2 249.1729 + 5 Venlafaxine 
N4-Acetyl-Sulfadiazine 127-74-2 C12H12N4O3S 292.0625 + 5 Sulfadiazine 
N4-Acetyl-Sulfadimethoxine 24341-30-8 C14H16N4O5S 352.0836 + 4 Sulfadimethoxine 
N4-Acetyl-Sulfamethazine 100-90-3 C14H16N4O3S 320.0938 + 2.5 Sulfamethazine 
N4-Acetyl-Sulfamethoxazole (N4-Acetyl- 21312-10-7 C12H13N3O4S 295.0621 + 3 Sulfamethoxazole 
Sulfamethoxazole-d5) 
N4-Acetyl-Sulfathiazole (N4-Acetyl-
Sulfathiazole-d4) 127-76-4 C11H11N3O3S2 297.0236 + 10 Sulfathiazole 
N-Desvenlafaxine 149289-30-5 C16H25N1O2 263.1885 + 0.5 Venlafaxine 
O-Desvenlafaxine 93413-62-8 C16H25N1O2 263.1885 + 1 Venlafaxine 
Oseltamivir-carboxylate 187227-45-8 C14H24N2O4 284.1731 + 10 Oseltamivir 
Ranitidine-N-oxide 738557-20-2 C13H22N4O4S 330.1362 + 2 Ranitidine 
Ranitidine-S-oxide 73851-70-4 C13H22N4O4S 330.1362 + 20 Ranitidine 
Ritalinic acid (Ritalinic acid-d10) 19395-41-6 C13H17NO2 219.1254 + 5 Methylphenidat 




BIOCIDES and METABOLITES 
2-Aminobenzimidazol 934-32-7 C7H7N3 133.0634 + 5 Carbendazim 
2-n-Octyl-4-isothiazolin-3-on 26530-20-1 C11H19NOS 213.1182 + 1 
 4,5-Dichloro-2-n-octyl-isothiazol-3(2H)-on 64359-81-5 C11H17Cl2NOS 281.0402 + 25 
 Carbendazim (Carbendazim-d4) 10605-21-7 C9H9N3O2 191.0689 + 3 
 Diuron (Diuron-d6) 330-54-1 C9H10Cl2N2O 232.0165 + 1 
 Diuron-desdimethyl  2327-02-8 C7H6Cl2N2O 203.9852 + 5 Diuron 
Diuron-desmonomethyl 3567-62-2 C8H8Cl2N2O 218.0008 + 5 Diuron 
Irgarol (Irgarol-d9) 28159-98-0 C11H19N5S 253.1356 + 2 
 Irgarol-descyclopropyl N/A C8H15N5S 213.1043 + 1 Irgarol 
N,N-diethyl-3-methylbenzamid 134-62-3 C12H17NO 191.1305 + 1 
 Prometryn  7287-19-6 C10H19N5S 241.1356 + 0.5 
 Propiconazole  (Propiconazole-d5) 60207-90-1 C15H17Cl2N3O2 341.0692 + 5 
 Terbutryn (Terbutryn-d5) 886-50-0 C10H19N5S 241.1356 + 0.5 
 Triclosan (Triclosan-d3) 3380-34-5 C12H7Cl3O2 287.9506 - 25   
ILLICIT DRUGS and METABOLITES 
1-(3-Chlorophenyl)-piperazine 6640-24-0 C10H13ClN2 196.0767 + 5 
 1-(3-Trifluoromethylphenyl)-piperazine 15532-75-9 C11H13F3N2 230.1031 + 20 
 1-Benzylpiperazine 2759-28-6 C11H16N2 176.1313 + 50 
 Amphetamine 300-62-9 C9H13N 135.1048 + 3 
 Benzoylecgonine 519-09-5 C16H19NO4 289.1314 + 2.5 Cocaine 
Cocaine 50-36-2 C17H21NO4 303.1471 + 1 
 Codeine (Codeine-
13
C, d3) 76-57-3 C18H21NO3 299.1521 + 1 
 
Diazepam (Diazepam-d5) 439-14-5 C16H13ClN2O 284.0716 + 1 
 2-Ethyliden-1,5-dimethyl-3,3-diphenylpyrrolidine 30223-73-5 C20H23N 277.183 + 5 Methadone 
Mephedrone 1189805-46-6 C11H15NO 177.1154 + 5 
 Methadone 76-99-3 C21H27NO 309.2093 + 0.5 
 Methamphetamine 537-46-2 C10H15N 149.1204 + 1 
 Morphine (Morphine-d3) 57-27-2 C17H19NO3 285.1359 + 2.5 
 Oxazepam (Oxazepam-d5) 604-75-1 C15H11ClN2O2 286.048 + 2.5   
FOOD ADDITIVES (Artificial Sweeteners) 
Acesulfame  (Acesulfame-d4) 55589-62-3 C4H5NO4S 162.9939 - 1 
 Aspartame (Aspartame-d5) 22839-47-0 C14H18N2O5 294.121 + 70 
 Cyclamate (Cyclamate-d11) 100-88-9 C6H13NO3S 179.0616 - 1.5 
 Neotame (Neotane-d3) 165450-17-9 C20H30N2O5 378.2155 + 5 
 Saccharine  (Saccharine 
13
C6) 81-07-2 C7H5NO3S 182.999 - 1 
 Sucralose  (Sucralose-d6) 56038-13-2 C12H19Cl3O8 396.0146 - 4   
INDUSTRIAL CHEMICALS 
1,2-Bis-(4,4'-dinitro-2,2'-disulfonic acid) 
-phenylethylenoxide 128-42-7 C14H10N2O10S2 429.9771 - 200 
 2-Naphthalinsulfonic acid 120-18-3 C10H8O3S 208.0189 - 30 
 4,4'-Diaminostilben-2,2'-disulfonic acid 81-11-8 C14H14N2O6S2 370.0288 - 20 
 N-(4-Aminophenyl)-N-methyl-acetamide 119-63-1 C9H12N2O 164.0944 + 5 
 N-Methylacetanilide 579-10-2 C9H11NO 149.0835 + 1   
CORROSION INHIBITORS 
1-Hydroxy-Benzotriazole 2592-95-2 C6H5N3O 135.0433 + 40 Benzotriazole 
1-Methyl-Benzotriazole 13351-73-0 C7H7N3 133.0635 + 1 Benzotriazole 
4 + 5-Methyl-Benzotriazole (5-Methyl-
Benzotriazole-d6) 136-85-6 C7H7N3 133.0635 + 50 
 4-Hydroxy-Benzotriazole 26725-51-9 C6H5N3O 135.0433 + 40 Benzotriazole 
Benzotriazole (Benzotrazole-d4) 95-14-7 C6H5N3 119.0478 + 25   
OTHERS 
Benzophenone 131-57-7 C14H12O3 228.0781 + 10 Personal care product 
Caffeine (Caffeine-d9) 58-08-2 C8H10N4O2 194.0798 + 50 Tracer 
Climbazole 38083-17-9 C15H17ClN2O2 292.0979 + 50 Personal care product 
Galaxolidon  (Surrogate: Propiconazole-d5) 256393-37-0 C18H24O2 272.1771 + 10 
Metabolite of 
Galaxolide 
NN-Dimethyldicylamin N-oxide 2605-79-0 C12H27NO 201.2093 + 2 Disinfectant 







N2; bisphenol-A-d16; ciprofloxacin-d8; erythromycin-
13
C2; irbesartan-d3; N,O-
didesmethylvenlaflaxin-d3; N-desmethylvenlaflaxin-d3; nelfinavir-d3; norfloxacin-d5; O-desmethylvenlaflaxin-d6; oxcarbazepine-d4. 
 
 







Source Voltage (kV)  4 3 
Capillary Temp (°C) 350 350 
Sheath Gas Flow (Arb) 40 40 
Aux Gas Flow (Arb) 10 10 
Sweep Gas Flow (Arb) 0 0 
Gas Heater Temp 50 50 
S-Lense-RF (V) 50 50 
Quadrupole scan range (m/z) 100-1000 100-1000 
FTMS Full AGC Target 5E5 5E5 
FTMS MS2 AGC Target 5E5 5E5 
Ion Trap and FT Micro Scans 1 1 
Dynamic exclusion  
for MS2 (sec) 
8 8 
FTMS Full Max Ion Time (ms) 250 250 
FTMS MSn Max Ion Time (ms) 250 250 
MS2 Isolation window (m/z) 1 1 









Table S3. Summary of the enviMass1.2 parameters adopted for quantitative 
screening of target substances. 
EnviMass Parameter Value 
blank subtraction 
m/z tolerance  10 ppm 
RT window 0.4 min 
Safety factor 4 
before recalibration 
m/z tolerance for internal 
standard 
10 ppm 
RT tolerance 1 min 
after recalibration 
m/z tolerance for targets 4 ppm 
RT tolerance 1 min 
RT tolerance for 
isotopic/adduct peak 
0.3 min 
Isotopic abundance tolerance 50% 
Intensity cut-off 5000 
RT: retention time; m/z: mass-to-charge ration 
 
Table S4. Summary of the Formulator parameters adopted for quantitative 
screening of target substances. 
Formulator Parameter Value 
Average by scan 3 
m/z tolerance ±5 ppm 
RT tolerance 1 min 
MassChromatogram S/N 0.85 
Signal threshold S/N 10 
RT window 0.5 - 20 min 
Average by scan 3 
m/z tolerance ± 5 ppm 









Table S5. Summary of the recovery percentages from a 100 ng spike. 
Recoveries are presented only for the 13 compounds which were 
subsequently detected in the post RO and post UV water samples. 
Chemical RO water +  
100 ng spike 
(ng in vial) 
RO water 
Blank 









1700 1300 N/A <LOD 
Benzotriazole* 2200 1600 N/A <LOD 
Galaxolidone 170 40 130% <LOD 
Lamotrigine 100 5 95% <LOD 
Metholachor 125 30 95% <LOD 
Metformin 325 220 105% <LOD 
Propiconazol 115 30 85% <LOD 
Prosulfocarb 110 25 85% <LOD 
Tramadol 110 1 109% <LOD 
Acesulfam 170 55 115% <LOD 
Saccharin 115 14 101% <LOD 
Sucralose 110 15 95% <LOD 





Table S6: Main physical-chemical properties of the chemicals that were detected in post RO and post UV water at 



















and industrial uses/ 
corrosion inhibitor 






129 12.4 -1.43 3449 Very poor1,2 




and industrial uses/ 
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396 11.8 0.68 64561 Good1,2 
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